IRIS
PERRICONE, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 54.909
EU - Europa 4.032
AS - Asia 2.095
SA - Sud America 21
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 7
Totale 61.086
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 54.858
SG - Singapore 1.051
DE - Germania 713
CN - Cina 701
UA - Ucraina 691
IT - Italia 578
IE - Irlanda 576
FR - Francia 374
RU - Federazione Russa 308
GB - Regno Unito 242
SE - Svezia 219
KR - Corea 161
FI - Finlandia 157
BE - Belgio 55
JP - Giappone 40
PL - Polonia 40
CA - Canada 31
IR - Iran 28
IN - India 23
VN - Vietnam 23
UZ - Uzbekistan 22
MX - Messico 20
BR - Brasile 15
ES - Italia 13
AU - Australia 12
NL - Olanda 11
AT - Austria 9
RO - Romania 9
CZ - Repubblica Ceca 8
PK - Pakistan 7
GR - Grecia 6
MY - Malesia 6
BD - Bangladesh 5
KG - Kirghizistan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EU - Europa 4
HK - Hong Kong 4
ID - Indonesia 4
SI - Slovenia 4
TR - Turchia 4
DK - Danimarca 3
IL - Israele 3
CH - Svizzera 2
CL - Cile 2
EG - Egitto 2
HR - Croazia 2
HU - Ungheria 2
MA - Marocco 2
NO - Norvegia 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
BJ - Benin 1
BY - Bielorussia 1
EC - Ecuador 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 61.086
Salva come PNG Salva come JPEG
Città #
Woodbridge 15.549
Wilmington 15.046
Houston 13.903
Fairfield 1.633
Ann Arbor 1.431
Chandler 1.084
Singapore 906
Ashburn 792
Seattle 629
Jacksonville 585
Cambridge 538
Dublin 509
Medford 418
New York 268
Beijing 253
Santa Clara 209
Lawrence 196
Dearborn 192
Rome 168
Zhengzhou 123
Menlo Park 79
San Diego 74
Moscow 72
Mülheim 71
Redwood City 70
Boardman 55
Brussels 49
Nanjing 46
Milan 44
Falls Church 41
Norwalk 40
Palo Alto 39
Shanghai 38
Kraków 36
Seoul 36
London 30
Mountain View 30
Hefei 29
Los Angeles 27
Chengdu 26
Kunming 26
San Mateo 26
Verona 26
University Park 24
Helsinki 21
Toronto 20
Dong Ket 16
Munich 16
Augusta 15
Guangzhou 15
Shenzhen 14
Jinan 13
The Dalles 13
Bassano del Grappa 12
Phoenix 12
Scottsdale 12
Esslingen am Neckar 11
Nürnberg 11
Saint Petersburg 10
Detroit 9
Las Vegas 9
Leawood 9
Ardabil 8
Chicago 8
Nanchang 8
Napoli 8
Nuremberg 8
Padova 8
San Francisco 8
Brno 7
Hounslow 7
Indiana 7
Kilburn 7
Redmond 7
Tokyo 7
Wuhan 7
Bologna 6
Fuzhou 6
Hangzhou 6
Hanoi 6
Mexico City 6
Peshawar 6
Acton 5
Dallas 5
Perugia 5
Saint Louis 5
Shenyang 5
Williamsburg 5
Aversa 4
Brisbane 4
Catania 4
Changsha 4
Enterprise 4
Guidonia 4
Kuala Lumpur 4
New Bedfont 4
Nottingham 4
Novi Velia 4
Sydney 4
São Paulo 4
Totale 55.923
Salva come PNG Salva come JPEG
Nome #
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 488
Gonadal mosaicism in hereditary angioedema 477
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 458
High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins 450
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 449
Complement and autoimmunity 444
Denaturing HPLC in laboratory diagnosis of hereditary angioedema 439
Vasculitides and the Complement System: a Comprehensive Review 439
Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG) 437
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 435
NK cells in autoimmunity: A two-edg'd weapon of the immune system 434
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 434
Anti-TNFα discontinuation in rheumatoid and psoriatic arthritis: Is it possible after disease remission? 433
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 432
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 431
Anti-thyroid antibodies and antiphospholipid syndrome: Evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters 430
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy 430
Prolactin and natural killer cells: Evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion 428
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion 426
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study 422
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 420
Role of the complement system in rheumatoid arthritis and psoriatic arthritis: Relationship with anti-TNF inhibitors 419
Glutathione: A key player in autoimmunity 418
C3 come indicatore di efficacia terapeutica in pazienti con artrite reumatoide in terapia con inibitori del TNFα 418
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy 418
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 416
Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study 416
Apremilast for the treatment of psoriasis. 414
High-dose intravenous immunoglobulin treatment activates complement in vivo 411
Evidence of impaired sense of smell in hereditary angioedema 411
Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: The experience of two Italian integrated Dermatology/Rheumatology outpatient clinics 411
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 410
Profile of certolizumab and its potential in the treatment of psoriatic arthritis 409
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 409
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 408
Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature review 408
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 407
Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group 407
Complement activation and sensitizing antibodies in lyme borreliosis - a microbial adherence immobilization assay for borrelia-burgdorferi (maia-bb) 405
Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine. 401
Prediction of early pregnancy maternal thyroid impairment in women affected with unexplained recurrent miscarriage. 399
An impaired endothelial dependent and independent vasodilation characterizes the myo-endothelial dysfunction in ssc patients 399
Adalimumab and polymyalgia rheumatica. clinical remission but persisting high levels of esr: a controversy 399
HELLP syndrome: A complication or a new autoimmune syndrome? 399
Autoantibodies in inflammatory arthritis 399
Complement system in rheumatoid arthritis: evidence of correlation with disease activity but not with anti-citrullinated protein antibodies 398
Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study 398
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 398
European consensus for gynecologycal and obstetric management of women with hereditary angioedema due to C1-inhibitor deficiency (HAE): PREHAEAT 397
The type I IFN system in rheumatoid arthritis 396
GM-CSF and pregnancy: Evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment 393
Occurrence of localized scleroderma morphea in a patient with rheumatoid arthritis treated with etanercept 393
Scleroderma heart involvement: non-invasive assessment of pathophysiological mechanism and its effect on prognosis 392
The European register of hereditary angioedema: Experience and preliminary results 391
Itch gene polymorphisms in healthy population and in patients affected by rheumatoid arthritis and atopic dermatitis 390
'Autoimmunity cutting edge at the 21st century. Representation of the 9th international congress of autoimmunity, nice, France 2014' 388
TREATMENT OF RECURRENT SPONTANEOUS ABORTION WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN 387
Antimyocardial Autoantibodies (AMCA) 387
Sistema complementare e artrite reumatoide: Correlazioni con autoanticorpi, caratteristiche cliniche e di laboratorio e farmaci anti-TNF α 387
Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis 387
Successful high dose intravenous immunoglobulin treatment of a pregnant patient affected with hypereosinophilia syndrome and antiphospholipid syndrome (aPL plus recurrent spontaneous abortion) 386
Behcet's disease and etanercept: eighty weeks of experience 385
Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. 384
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implication 384
The autoimmune side of hereditary angioedema: Insights on the pathogenesis 384
The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies 383
Anti-Saccharomyces cerevisiae Autoantibodies in Autoimmune Diseases: from Bread Baking to Autoimmunity 383
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 382
Adalimumab corrects long-term endothelial dysfunction in rheumatoid arthritis 380
Auto-reactions, autoimmunity and psoriatic arthritis 378
Inhibition of the complement system by glutathione: molecular mechanisms and potential therapeutic implications 376
ADA genetic polymorphism and total plasma IgE level in healthy adults 376
Discontinuation of anti-TNFα therapy due to remission in rheumatoid arthritis: A retrospective study 375
Functionally active complement is present in human ovarian follicular fluid and can be activated by seminal plasma. 372
Complement system in psoriatic arthritis: a useful marker and a potential therapeutic target of anti-tnf-alpha treatment 372
Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab 372
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 372
The interplay between inflammation and metabolism in rheumatoid arthritis 371
Small-medium vessel vasculitides: Is the complement system a potential forgotten target? 371
BETA ENDORPHIN INTERACTION WITH LFA 1 (CD11A/CD18) ON HUMAN PERIPHERAL BLOOD LYMPHOCYTES 369
Hereditary angioneurotic edema: clinical and laboratory findings in 58 subjects 369
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 369
NK cells, autoantibodies, and immunologic infertility: a complex interplay 367
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 366
Prediction of early pregnancy maternal thyroid impairment in women affected with unexplained recurrent miscarriage. 365
Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment 365
Insights on the role of physical activity in patients with rheumatoid arthritis 364
Serum thymosin alpha 1 levels in normal and pathological conditions 364
Cystic ovaries in women affected with hereditary angioedema. 363
C1 Inhibitor Autoantibodies 363
Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines 362
Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways 362
Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis 361
Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroups in Italy 361
Comment on: Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion: reply 361
Remission of psoriatic arthritis after etanercept discontinuation: analysis of patients' clinical characteristics leading to disease relapse 358
The significance the role of anti-tnf-alpha effects on endothelial dysfunction in psoriasic arthritis 357
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 357
Invitro effect of 2 related forms of interferons (beta and alpha) on nk activity of patients with hairy-cell leukemia 356
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 355
Totale 39.729
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.939
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011.370 0 0 0 0 1.311 1.854 1.413 1.575 1.561 1.455 1.073 1.128
2020/202110.891 1.225 1.298 1.193 1.269 1.218 1.144 1.340 1.126 359 240 382 97
2021/20222.080 108 221 157 118 84 128 101 99 101 198 180 585
2022/20232.657 241 230 97 369 252 582 205 162 264 39 154 62
2023/20241.028 132 41 48 35 85 317 29 106 19 26 16 174
2024/20252.000 181 984 494 275 66 0 0 0 0 0 0 0
Totale 61.819